September 2007 - IOZK

Monocyte derived dendritic cells generated by IFN-alpha acquire mature dendritic and natural killer cell properties as shown by gene expression analysis

2007-09-25/in International Publications, Malignant Lymphoma /von 2007-09-25 / J Transl Med 2007 Sep;5:46

Regression of intestinal adenomas by vaccination with heat shock protein 105-pulsed bone marrow-derived dendritic cells in Apc(Min/+) mice

2007-09-24/in Dendritic Cells, Hyperthermia, International Publications /von 2007-09-24 / Cancer Sci. 2007 Dec;98(12):1930-5

Long-term improvement in treatment outcome after radiotherapy and hyperthermia in locoregionally advanced cervix cancer: an update of the Dutch Deep Hyperthermia Trial

2007-09-19/in Cervical Cancer, International Publications /von 2007-09-19 / Int. J. Radiat. Oncol. Biol. Phys. 2008 Mar;70(4):1176-82

Induction of protective CTL immunity against peptide transporter TAP-deficient tumors through dendritic cell vaccination

2007-09-15/in International Publications, Malignant Lymphoma /von 2007-09-15 / Cancer Res. 2007 Sep;67(18):8450-5

Plasmacytoid dendritic cells represent a major dendritic cell subset in sentinel lymph nodes of melanoma patients and accumulate in metastatic nodes

2007-09-10/in International Publications, Malignant Melanoma /von 2007-09-10 / Clin. Immunol. 2007 Nov;125(2):184-93

An immunotherapy approach with dendritic cells genetically modified to express the tumor-associated antigen, HER2

2007-09-05/in Breast Cancer, International Publications /von 2007-09-05 / Cancer Immunol. Immunother. 2008 May;57(5):611-22

Comparison of dendritic cell-mediated immune responses among canine malignant cells

2007-09-01/in International Publications, Malignant Lymphoma /von 2007-09-01 / J. Vet. Med. Sci. 2007 Sep;69(9):925-30

Use of reverse genetics to enhance the oncolytic properties of Newcastle disease virus

2007-09-01/in International Publications, Newcastle Disease Virus /von 2007-09-01 / Cancer Res. 2007 Sep;67(17):8285-92

Combined treatment of dendritoma vaccine and low-dose interleukin-2 in stage IV renal cell carcinoma patients induced clinical response: A pilot study

2007-09-01/in Hypernephroma, International Publications /von 2007-09-01 / Oncol. Rep. 2007 Sep;18(3):665-71

Targeting molecular and cellular inhibitory mechanisms for improvement of antitumor memory responses reactivated by tumor cell vaccine

2007-09-01/in Hypernephroma, International Publications /von 2007-09-01 / J. Immunol. 2007 Sep;179(5):2860-9